Researchers Discover Hundreds of Unexpected Mutations from New Gene Editing Technology
By Jessica Wapner,
Newsweek
| 05. 31. 2017
For the past few years, a new scientific tool known as CRISPR-Cas9 has been hailed as the future of medicine. The technology, which has been the center of both extreme fascination and a bitter patent disputebetween two research groups, enables scientists to edit genomes. That is, they can remove harmful genes that cause diseases and replace them with normal genes that don’t—at least in theory. While exciting to many, the idea has also elicited fears that the technology could create dangerous mutations and be used in unbridled ways, for example in attempts to create superhumans and designer babies.
According to a new report, such fears may be well founded. The study, published in Nature Methods , found that using CRISPR-Cas9 to edit a genome can result in hundreds of unintended mutations being introduced. For the report, researchers sequenced the genomes of mice that had already undergone CRISPR-Cas9 procedures. They then scrutinized the edited genomes for any changes in the mouse genes—and they found plenty. The technology had accomplished the original intended task of correcting a gene that causes...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...